Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Results Update

Aurobindo Pharma Results Update

Aurobindo Pharma reported Q4FY26 revenue of ₹8,853 Crore, a 5.6% YoY increase. Net profit rose 2.0% to ₹921 Crore, supported by strong European business growth.

Key figures
Value₹8,853 Cr
Source

NSE filing, NSE: AUROPHARMA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aurobindo Pharma Ltd: key numbers

Share price
₹1,705.00
Market cap
₹99,027 Cr
Revenue (annual)
₹33,653 Cr
Net profit (annual)
₹3,505 Cr
P/E (TTM)
25.1×Sector 37.9×
Promoter holding
51.88%+0.00% QoQ
FII holding
17.41%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aurobindo Pharma Ltd

All →

Other results update announcements

All →